Medicare today proposed to cover surgeries to fix or replace leaky heart valves called transcatheter mitral valve procedures, issuing a draft National Coverage Decision for the procedure.
Abbott
Abbott to expand medical device footprint? | Medtech Wall Street news for the week of May 12, 2014
Abbott claims win over Medinol in Dutch stent patent fight
Abbott may look to expand medical device business footprint
Abbott’s vascular device plant in Ireland claims Shingo Prize | MassDevice.com On Call
Abbott paid $3M to Mass. docs in 2012
FDA warns on Hospira, Abbott infusion pump recall | MassDevice.com On Call
Abbott’s earnings take a beating in Q1
Abbott closes 3 clinical trials for disappearing drug-eluting coronary stent
Analyst speculates Smith & Nephew split | Medtech Wall Street news for the week of Mar. 31, 2014
ACC 2014 Roundup: Study shows long-term benefits for some CRT-D patients
Some patients with mild heart failure show significant, long-term benefits from cardiac-resynchronization therapy, according to the 7-year results from Boston Scientific‘s (NYSE:BSX) MADIT-CRT clinical trial presented at the American College of Cardiology’s annual meeting over the weekend.